To determine the evolution of prostatic multi-parametric magnetic resonance imaging (mp-MRI) signal following transrectal ultrasound (TRUS)-guided biopsy. Significant PZ (but not TZ) T2 signal ...

A transrectal ultrasound scan (TRUS) is an examination of the prostate gland using ultrasound. The doctor puts an ultrasound probe into your rectum. They might take samples of tissue from the prostate ...

A prostate biopsy uses transrectal ultrasound imaging (meaning it goes through the lining of your rectum) to guide several small needles through the rectum wall into areas of the prostate where ...

Table 1 CPE and PCR results of rectum, sputum, and urine swab samples The systemic distribution of adenovirus after transrectal ultrasound-guided prostate biopsy and injection has not been ...

The issue of transrectal versus TP biopsies has been simmering worldwide in recent years. The European Association of Urology not long ago adopted a guideline that designated TP as the preferred ...

A transrectal ultrasound (TRUS) of the prostate may also be called a prostate sonogram or endorectal ultrasound. A doctor usually performs a TRUS to help diagnose prostate cancer or detect ...

The procedure, known as a transrectal biopsy, has been considered the gold standard for diagnosing prostate cancer, a condition that affects roughly one in eight American men during their lifetimes.

About two million American men undergo transrectal biopsies each year to diagnose prostate cancer or to monitor low-risk and favorable intermediate-risk prostate cancers for active surveillance (AS).

Radiographic-pathologic concordance in the workup of locally radiorecurrent prostate cancer. Detection of true positive M1 lesions by 18F-rhPSMA-7.3 PET in newly diagnosed prostate cancer: Results ...

This is called the transrectal route. Researchers and doctors have been looking for ways to improve the needle biopsy process, largely due to the concern of infections from the biopsy process. One ...

Patient-reported health-related quality of life (HRQoL) in the randomized FORMULA-509 trial of salvage radiotherapy and 6 months of GnRH agonist with either bicalutamide or abiraterone acetate plus ...